Home / Tren A Injection 10 ML
Tren A Injection 10 ML

Tren A Injection 10 ML

(0 customer reviews)

$59.98 / unit

Available Options

Pack SizePricePrice / UnitQuantityAction
10 Injection$450.00$45.00/unit
8 Injection$360.00$45.00/unit
6 Injection$273.00$45.50/unit
4 Injection$191.00$47.75/unit
2 Injection$108.00$54.00/unit
1 Injection$60.00$60.00/unit
Looking for bulk / B2B pricing?

Product Description

What is this medicine?

TREN A INJECTION contains Trenbolone Acetate, a potent synthetic anabolic-androgenic steroid (AAS).

Current products sold under the TREN A/TREN-A name include different presentations.

One current Indian seller lists:

  • Brand Name: TREN A

  • Active Ingredient: Trenbolone Acetate

  • Listed Strength: 100 mg

  • Vial Size: 10 mL

  • Manufacturer: John Albert Pharma

Another current product, from Zovexa Pharma, is labeled:

  • Brand Name: TREN-A

  • Active Ingredient: Trenbolone Acetate

  • Strength: 150 mg/mL

  • Vial Size: 10 mL

  • Route: For I.M. use only

Therefore, do not assume that every TREN A 10 mL vial is 100 mg/mL. Verify the exact concentration printed on your physical product before calculating total vial content or publishing the strength.

Trenbolone acetate is an ester of trenbolone, a synthetic androgen with strong anabolic and androgenic activity. FDA's substance database recognizes trenbolone acetate as a drug substance, but specifically states that inclusion in the database does not imply regulatory review or approval.

Trenbolone can affect:

  • androgen-responsive tissues

  • protein metabolism

  • muscle tissue

  • natural reproductive-hormone production

  • sperm production and fertility

  • red blood cell production

  • blood pressure

  • cholesterol

  • cardiovascular function

  • mood and behavior

Human regulatory status

I could not verify an FDA-approved trenbolone acetate injection for human therapeutic use.

Current FDA-approved trenbolone acetate products are found in the veterinary cattle-implant setting, where trenbolone acetate is used alone or with other hormones to improve growth rate and feed efficiency in cattle.

For example, FDA documentation for Finaplix identifies:

  • Active Ingredient: Trenbolone Acetate

  • Dosage Form: Pellet

  • Route: Ear implant

  • Species: Cattle

—not human intramuscular therapy.

Therefore, TREN A should not be described as an FDA-approved human treatment for:

  • low testosterone

  • testosterone replacement therapy

  • muscle wasting

  • bodybuilding

  • cutting

  • athletic-performance enhancement

  • cosmetic muscle gain


What should I tell my health care provider before I take this medicine?

Tell your healthcare provider about your complete medical history, particularly if you have:

  • heart disease

  • previous heart attack

  • previous stroke

  • high blood pressure

  • abnormal cholesterol or triglycerides

  • history of blood clots

  • high haemoglobin or haematocrit

  • polycythaemia

  • kidney disease

  • liver disease

  • prostate enlargement

  • prostate cancer

  • male breast cancer

  • diabetes

  • sleep apnoea

  • epilepsy

  • migraine

  • fertility problems

  • plans to father a child

  • erectile or sexual-function problems

  • anxiety

  • depression

  • severe irritability or aggression

  • another psychiatric condition

  • significant swelling or fluid retention

Also tell your healthcare provider if you use:

Fertility warning

Anabolic-androgenic steroids can suppress the hypothalamic-pituitary-gonadal axis, reducing the body's production of reproductive hormones.

Possible effects in men include:

  • reduced natural testosterone production

  • reduced sperm production

  • oligospermia

  • azoospermia

  • testicular shrinkage

  • decreased fertility

  • infertility

  • erectile dysfunction

  • changes in sexual desire

A systematic review of AAS exposure found associations with testicular atrophy, azoospermia and anabolic-steroid-induced hypogonadism.

Recovery after stopping anabolic steroids varies significantly between individuals and can take considerable time.

Pregnancy warning

Trenbolone is a potent androgenic substance.

Androgen exposure during pregnancy may interfere with normal fetal sexual development. Pregnant women should avoid exposure to anabolic-androgenic steroids unless specifically directed in an authorized medical context.


How should I use this medicine?

There is no verified regulator-approved standard human dosing regimen for TREN A Trenbolone Acetate Injection.

This is particularly important because current products using the TREN A/TREN-A name are sold in different concentrations.

For example:

  • one current TREN A listing states 100 mg, 10 mL

  • Zovexa Pharma TREN-A is explicitly labeled 150 mg/mL, 10 mL

If a physical vial is labeled 100 mg/mL, a 10 mL vial would contain a nominal 1,000 mg in total.

If a physical vial is labeled 150 mg/mL, a 10 mL vial would contain a nominal 1,500 mg in total.

The total amount in a 10 mL vial is not a recommended dose.

No authoritative human prescribing information could be verified establishing for this product:

  • a recommended human starting dose

  • a maintenance dose

  • a standard injection frequency

  • a maximum safe human dose

  • an approved treatment duration

  • a bodybuilding cycle

  • a cutting cycle

FDA documentation instead describes trenbolone acetate in cattle implant products. Some FDA animal-drug labeling explicitly states “FOR USE IN ANIMALS ONLY – NOT FOR HUMAN USE.”

For this reason:

  • do not determine a dose from bodybuilding forums

  • do not assume 1 mL is an appropriate dose

  • never assume the whole 10 mL vial is a dose

  • do not increase the amount for faster muscle gain

  • do not shorten injection intervals

  • do not use veterinary dosing information in humans

  • do not combine trenbolone with other anabolic steroids based on a bodybuilding “stack”

  • do not substitute trenbolone for medically prescribed testosterone replacement therapy

If a person is already using or has recently used trenbolone, a healthcare professional may consider monitoring:

  • blood pressure

  • complete blood count

  • haemoglobin

  • haematocrit

  • cholesterol

  • LDL cholesterol

  • HDL cholesterol

  • triglycerides

  • kidney function

  • liver function

  • blood glucose

  • testosterone

  • LH

  • FSH

  • fertility parameters where appropriate

  • cardiovascular symptoms

  • psychiatric symptoms

There is no medically established universal “Tren A cycle” that should be presented as a therapeutic regimen.


What if I miss a dose?

Because TREN A does not have a verified regulator-approved human therapeutic dosing schedule, there is no standardized human missed-dose recommendation.

Do not:

  • inject an extra amount

  • double the next amount

  • shorten the injection interval

  • use additional medicine to compensate

  • follow a steroid-cycle schedule to replace a missed injection

If the exact product has been supplied under legitimate medical supervision in a jurisdiction where it has an authorized indication, follow the instructions of the prescribing healthcare professional.


What may interact with this medicine?

Controlled human drug-interaction studies specifically involving trenbolone acetate injections are very limited, so a complete evidence-based interaction list cannot be established.

Nevertheless, tell your healthcare provider if you take:

  • warfarin

  • other anticoagulants

  • insulin

  • oral diabetes medicines

  • corticosteroids

  • ACTH

  • testosterone

  • nandrolone

  • drostanolone

  • stanozolol

  • oxandrolone

  • oxymetholone

  • methandienone

  • other anabolic steroids

  • blood-pressure medicines

  • medicines affecting cholesterol

  • medicines affecting fluid balance

Other anabolic-androgenic steroids

Combining trenbolone with other anabolic steroids can substantially increase total androgen exposure.

This may compound risks involving:

  • blood pressure

  • cholesterol

  • cardiovascular function

  • red blood cell count

  • reproductive-hormone suppression

  • fertility

  • sexual function

  • mood and behavior

AAS misuse is associated with multisystem toxicity, particularly involving the cardiovascular and reproductive systems.

Anticoagulants

Because androgenic-anabolic steroids as a class may affect coagulation and cardiovascular risk factors, anyone using anticoagulants such as warfarin should disclose anabolic-steroid exposure to their healthcare professional.

Diabetes medicines

Anabolic-androgenic steroids may affect metabolic and glucose regulation.

People receiving:

  • insulin

  • sulfonylureas

  • metformin

  • other glucose-lowering treatment

should disclose anabolic-steroid exposure so blood glucose can be monitored appropriately.

Give your healthcare professional a complete list of all:

  • prescription medicines

  • non-prescription medicines

  • injections

  • hormones

  • vitamins

  • supplements

  • herbal medicines

  • performance-enhancing substances


What should I watch for while using this medicine?

Seek prompt medical attention if you develop:

  • chest pain

  • sudden shortness of breath

  • fainting

  • rapid or irregular heartbeat

  • severe or persistent high blood pressure

  • severe unexplained headache

  • sudden weakness or numbness

  • pain or swelling in one leg

  • major ankle or leg swelling

  • major reduction in urine output

  • yellowing of the skin or eyes

  • dark urine

  • severe anxiety

  • severe depression

  • extreme aggression

  • suicidal thoughts

  • prolonged or painful erection

  • severe allergic reaction

Cardiovascular health

Anabolic-androgenic steroid misuse has been linked with significant cardiovascular problems.

Potential complications include:

  • hypertension

  • unfavorable cholesterol changes

  • increased haematocrit

  • thrombosis

  • arrhythmias

  • cardiomyopathy

  • impaired heart function

  • myocardial infarction

  • stroke

Recent and earlier medical reviews consistently identify cardiovascular disease as a major concern with chronic supraphysiologic anabolic-steroid exposure.

Cholesterol

Anabolic-androgenic steroids may produce unfavorable changes such as:

  • reduced HDL cholesterol

  • increased LDL cholesterol

  • altered triglycerides

These changes can contribute to long-term cardiovascular risk.

Red blood cell count

AAS exposure can increase:

  • red blood cell count

  • haemoglobin

  • haematocrit

Excessive haematocrit may increase blood viscosity and contribute to:

  • thrombosis

  • stroke

  • other cardiovascular complications

A clinical review specifically identifies increased haematocrit and coagulation among important adverse effects of high-dose AAS exposure.

Hormonal suppression

Trenbolone and other anabolic steroids can suppress normal reproductive-hormone production.

Possible consequences include:

  • low endogenous testosterone

  • reduced sperm production

  • testicular shrinkage

  • infertility

  • changes in sexual desire

  • erectile dysfunction

AAS-associated reproductive dysfunction may be temporary in some individuals but may persist for prolonged periods in others.

Kidney health

Long-term or high-dose AAS misuse has been associated with kidney injury in addition to cardiovascular and endocrine complications. MedlinePlus includes kidney damage among recognized harms of anabolic-steroid misuse.

Seek medical attention if you notice:

  • markedly reduced urine output

  • blood in the urine

  • severe swelling

  • unexplained shortness of breath

Psychiatric effects

Anabolic-androgenic steroid misuse may be associated with:

  • irritability

  • aggression

  • anxiety

  • insomnia

  • mood changes

  • depressive symptoms

  • dependence

  • withdrawal symptoms

MedlinePlus specifically identifies irritability and aggressive behavior among possible consequences of anabolic-steroid misuse.

Women

Potent androgen exposure may cause virilizing effects such as:

  • acne

  • increased facial or body hair

  • scalp hair loss

  • menstrual irregularities

  • deepening of the voice

  • clitoral enlargement

Some androgenic changes, especially voice deepening, may not fully reverse.

Children and adolescents

Anabolic steroid exposure can interfere with normal growth and endocrine development.

Possible consequences include:

  • premature skeletal maturation

  • growth-plate closure

  • reduced final adult height

  • abnormal sexual development

MedlinePlus identifies stunted growth in teenagers as a recognized risk of anabolic-steroid misuse.

Athletic competition

Trenbolone is specifically listed under S1 Anabolic Agents in the 2026 WADA Prohibited List and is prohibited at all times, both in and out of competition.

Misuse warning

TREN A should not be considered medically safe simply because it is supplied in a pharmaceutical-style vial.

Non-medical use for:

  • bodybuilding

  • bulking

  • cutting

  • muscle definition

  • strength enhancement

  • athletic performance

  • cosmetic physique enhancement

can expose users to serious cardiovascular, endocrine, reproductive, renal and psychiatric risks.


What side effects may I notice from this medicine?

Because trenbolone acetate does not have a verified modern approved human prescribing label, reliable clinical-trial frequencies for human adverse reactions are not available.

Side effects that should receive prompt medical attention:

  • chest pain

  • severe shortness of breath

  • fainting

  • severe or persistent high blood pressure

  • rapid or irregular heartbeat

  • symptoms of a possible blood clot

  • severe neurological symptoms

  • significant swelling

  • serious kidney symptoms

  • yellowing of the skin or eyes

  • severe mood or behavioral changes

  • severe depression

  • suicidal thoughts

  • prolonged or painful erection

  • severe allergic reaction

Other possible effects associated with anabolic-androgenic steroid exposure:

  • acne

  • oily skin

  • increased sweating

  • headache

  • insomnia

  • irritability

  • anxiety

  • mood changes

  • changes in sexual desire

  • elevated blood pressure

  • abnormal cholesterol

  • increased haemoglobin or haematocrit

  • reduced sperm production

  • testicular shrinkage

  • reduced fertility

  • erectile or sexual-function changes

  • injection-site discomfort

MedlinePlus identifies acne, high blood pressure, cholesterol changes, heart problems, kidney damage, mood changes and male infertility among recognized harms associated with anabolic-steroid misuse.

In women, possible androgenic effects include:

  • facial or body-hair growth

  • acne

  • menstrual changes

  • male-pattern scalp hair loss

  • deepening of the voice

  • clitoral enlargement

This list may not describe all possible adverse effects.


Where should I keep my medicine?

Keep TREN A 10 ML INJECTION out of the reach of children.

Because products sold as TREN A come from different manufacturers and concentrations, follow the exact storage instructions printed on the original vial and carton.

Do not transfer storage instructions from one TREN A manufacturer to another.

In general, keep the vial:

  • in its original packaging

  • protected from excessive heat

  • protected from direct sunlight

  • protected from contamination

  • protected from physical damage

  • away from unauthorized access

Do not use the product if:

  • the vial is cracked

  • the seal is damaged or appears tampered with

  • the solution contains unexpected particles

  • the solution has changed appearance

  • contamination is suspected

  • the expiration date has passed

  • authenticity cannot be verified

Because a 10 mL vial may be intended as a multidose presentation, strict sterile handling is particularly important.

Never share needles or syringes.